Norifumi Kawada

Norifumi Kawada's AcademicInfluence.com Rankings

Norifumi Kawada

Medical

#3067

World Rank

#3519

Historical Rank

Pharmacology

#361

World Rank

#412

Historical Rank

medical Degrees

Download Badge

Medical

Norifumi Kawada's Degrees

PhD Pharmacology University of Tokyo
Masters Pharmacology University of Tokyo
Bachelors Pharmacy University of Tokyo

Why Is Norifumi Kawada Influential?

(Suggest an Edit or Addition)

(See a Problem?)

Norifumi Kawada's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

Angiotensin II type 2 receptor overexpression activates the vascular kinin system and causes vasodilation. (1999) (577)
Daclatasvir Plus Asunaprevir for Chronic HCV Genotype 1b Infection (2014) (538)
Effect of antioxidants, resveratrol, quercetin, and N‐acetylcysteine, on the functions of cultured rat hepatic stellate cells and kupffer cells (1998) (411)
The contraction of hepatic stellate (Ito) cells stimulated with vasoactive substances. Possible involvement of endothelin 1 and nitric oxide in the regulation of the sinusoidal tonus. (1993) (387)
Characterization of a Stellate Cell Activation-associated Protein (STAP) with Peroxidase Activity Found in Rat Hepatic Stellate Cells* (2001) (322)
[Drug-induced cholestasis]. (1995) (291)
Validation of the FIB4 index in a Japanese nonalcoholic fatty liver disease population (2011) (288)
Effects of sho‐saiko‐to, a japanese herbal medicine, on hepatic fibrosis in rats (1999) (239)
MicroRNA-221/222 upregulation indicates the activation of stellate cells and the progression of liver fibrosis (2012) (224)
Proteome analysis of rat hepatic stellate cells (2000) (204)
A simple clinical scoring system using ferritin, fasting insulin, and type IV collagen 7S for predicting steatohepatitis in nonalcoholic fatty liver disease (2011) (185)
In Vitro Migratory potential of rat quiescent hepatic stellate cells and its augmentation by cell activation (1999) (161)
Suppression of hepatic stellate cell activation by microRNA-29b. (2011) (155)
Eicosanoid-mediated contractility of hepatic stellate cells. (1992) (152)
Erythrophagocytosis by liver macrophages (Kupffer cells) promotes oxidative stress, inflammation, and fibrosis in a rabbit model of steatohepatitis: implications for the pathogenesis of human nonalcoholic steatohepatitis. (2007) (141)
Prospective study of reactivation of hepatitis B virus in patients with rheumatoid arthritis who received immunosuppressive therapy: evaluation of both HBsAg-positive and HBsAg-negative cohorts (2011) (137)
Adenovirus-mediated expression of BMP-7 suppresses the development of liver fibrosis in rats (2006) (136)
Inflammation and fibrogenesis in steatohepatitis (2012) (135)
Stimulation of Proliferation of Rat Hepatic Stellate Cells by Galectin-1 and Galectin-3 through Different Intracellular Signaling Pathways* (2003) (135)
Cytoglobin/STAP, its unique localization in splanchnic fibroblast-like cells and function in organ fibrogenesis (2004) (133)
Suppression of type I collagen production by microRNA-29b in cultured human stellate cells. (2010) (127)
Localization of oxidized phosphatidylcholine in nonalcoholic fatty liver disease: Impact on disease progression (2006) (125)
Increased expression of plasminogen activator and plasminogen activator inhibitor during liver fibrogenesis of rats: role of stellate cells. (1999) (118)
Prevention of rat hepatic fibrosis by the protease inhibitor, camostat mesilate, via reduced generation of active TGF-beta. (2001) (117)
Interferon alfa down‐regulates collagen gene transcription and suppresses experimental hepatic fibrosis in mice (2003) (116)
BMP-7 opposes TGF-beta1-mediated collagen induction in mouse pulmonary myofibroblasts through Id2. (2006) (105)
Structural basis of human cytoglobin for ligand binding. (2004) (104)
Platelet count for predicting fibrosis in nonalcoholic fatty liver disease (2011) (102)
Retinoids exacerbate rat liver fibrosis by inducing the activation of latent TGF‐β in liver stellate cells (1997) (101)
Overexpression of thioredoxin prevents acute hepatitis caused by thioacetamide or lipopolysaccharide in mice (2003) (97)
Real-time tissue elastography as a tool for the noninvasive assessment of liver stiffness in patients with chronic hepatitis C (2011) (95)
Endothelin‐1–induced vasoconstriction causes a significant increase in portal pressure of rat liver: Localized constrictive effect on the distal segment of preterminal portal venules as revealed by light and electron microscopy and serial reconstruction (1998) (94)
Role of the Gut–Liver Axis in Liver Inflammation, Fibrosis, and Cancer: A Special Focus on the Gut Microbiota Relationship (2019) (94)
Case series of 17 patients with cholangiocarcinoma among young adult workers of a printing company in Japan (2014) (92)
Characterization of the heme environmental structure of cytoglobin, a fourth globin in humans. (2003) (91)
Genome-Wide Association Study Identifies TLL1 Variant Associated With Development of Hepatocellular Carcinoma After Eradication of Hepatitis C Virus Infection. (2017) (89)
Physical inactivity and insufficient dietary intake are associated with the frequency of sarcopenia in patients with compensated viral liver cirrhosis (2013) (89)
Development of hepatocellular carcinoma in patients with chronic hepatitis C who had a sustained virological response to interferon therapy: a multicenter, retrospective cohort study of 1124 patients (2007) (88)
Clinical course and risk factors for mortality of COVID-19 patients with pre-existing cirrhosis: a multicentre cohort study (2020) (87)
Expression of perilipin and adipophilin in nonalcoholic fatty liver disease; relevance to oxidative injury and hepatocyte ballooning. (2009) (86)
ROCK inhibitor Y-27632 attenuates stellate cell contraction and portal pressure increase induced by endothelin-1. (1999) (85)
Branched-chain amino acids prevent hepatocarcinogenesis and prolong survival of patients with cirrhosis. (2014) (85)
Comprehensive analysis of transcriptome and metabolome analysis in Intrahepatic Cholangiocarcinoma and Hepatocellular Carcinoma (2015) (84)
Cell type-specific intervention of transforming growth factor beta/Smad signaling suppresses collagen gene expression and hepatic fibrosis in mice. (2005) (82)
Increased 9,13-di-cis-retinoic acid in rat hepatic fibrosis: implication for a potential link between retinoid loss and TGF-beta mediated fibrogenesis in vivo. (1999) (82)
Down‐regulation of cyclin E1 expression by microrna‐195 accounts for interferon‐β‐induced inhibition of hepatic stellate cell proliferation (2011) (81)
Role of hepatitis B virus DNA integration in human hepatocarcinogenesis. (2014) (81)
Inhibition of hepatic stellate cell proliferation and activation by the semisynthetic analogue of fumagillin TNP‐470 in rats (2000) (79)
Impaired liver regeneration in mice by lipopolysaccharide via TNF-α/kallikrein–mediated activation of latent TGF-β (2002) (79)
Promotion of liver and lung tumorigenesis in DEN-treated cytoglobin-deficient mice. (2011) (78)
The hepatic perisinusoidal stellate cell. (1997) (77)
The Role of Insulin Resistance and Diabetes in Nonalcoholic Fatty Liver Disease (2020) (77)
Induction of microRNA-214-5p in human and rodent liver fibrosis (2012) (76)
Overexpression of thioredoxin prevents thioacetamide-induced hepatic fibrosis in mice. (2005) (74)
Regulation of endothelin‐1 action on the perfused rat liver (1993) (73)
Assessment of Liver Fibrosis with Real-Time Tissue Elastography in Chronic Viral Hepatitis (2013) (73)
Outcomes of dysplastic nodules in human cirrhotic liver: a clinicopathological study. (2000) (73)
The combination of elbasvir and grazoprevir for the treatment of chronic HCV infection in Japanese patients: a randomized phase II/III study (2016) (72)
Comparison of Hepatocellular Carcinoma miRNA Expression Profiling as Evaluated by Next Generation Sequencing and Microarray (2014) (71)
Inhibition of Transforming Growth Factor &bgr; Signaling by Halofuginone as a Modality for Pancreas Fibrosis Prevention (2009) (70)
Interferon alfa down-regulates collagen gene transcription and suppresses experimental hepatic fibrosis in mice. (2003) (70)
Bezafibrate Improves GLOBE and UK‐PBC Scores and Long‐Term Outcomes in Patients With Primary Biliary Cholangitis (2019) (69)
Cytoglobin regulates blood pressure and vascular tone through nitric oxide metabolism in the vascular wall (2017) (69)
Kupffer cell-mediated down regulation of rat hepatic CMOAT/MRP2 gene expression. (1999) (68)
The expression level of miR-18b in hepatocellular carcinoma is associated with the grade of malignancy and prognosis (2013) (67)
Quantitative detection of hepatitis B surface antigen by chemiluminescent microparticle immunoassay during lamivudine treatment of chronic hepatitis B virus carriers (2005) (67)
Hepatic sinusoidal cells in health and disease: update from the 14th International Symposium (2009) (67)
Herb medicine Inchin-ko-to (TJ-135) regulates PDGF-BB-dependent signaling pathways of hepatic stellate cells in primary culture and attenuates development of liver fibrosis induced by thioacetamide administration in rats. (2004) (65)
Expression of neural cell adhesion molecule (N-CAM) in perisinusoidal stellate cells of the human liver (1995) (65)
Retinoids exacerbate rat liver fibrosis by inducing the activation of latent TGF-beta in liver stellate cells. (1997) (64)
A novel noninvasive diagnostic method for nonalcoholic steatohepatitis using two glycobiomarkers (2015) (64)
Structural characterization of the proximal and distal histidine environment of cytoglobin and neuroglobin. (2005) (63)
In vivo and in vitro Interactions between Human Colon Carcinoma Cells and Hepatic Stellate Cells (2000) (59)
Serum Fucosylated Haptoglobin as a Novel Diagnostic Biomarker for Predicting Hepatocyte Ballooning and Nonalcoholic Steatohepatitis (2013) (59)
Transient Elastography-Based Liver Profiles in a Hospital-Based Pediatric Population in Japan (2015) (59)
Pathogenesis of adult-onset type II citrullinemia caused by deficiency of citrin, a mitochondrial solute carrier protein: tissue and subcellular localization of citrin. (2001) (58)
HOMA‐IR: An independent predictor of advanced liver fibrosis in nondiabetic non‐alcoholic fatty liver disease (2019) (58)
Add‐on combination therapy with adefovir dipivoxil induces renal impairment in patients with lamivudine‐refractory hepatitis B virus (2010) (56)
Cytoglobin, a novel member of the globin family, protects kidney fibroblasts against oxidative stress under ischemic conditions. (2011) (56)
Evolution of hepatic fibrosis research (2011) (56)
Usefulness of transient elastography for assessment of liver fibrosis in chronic hepatitis B: Regression of liver stiffness during entecavir therapy (2010) (56)
Reversibility of fibrosis, inflammation, and endoplasmic reticulum stress in the liver of rats fed a methionine–choline-deficient diet (2010) (56)
Recent Advances in Antiviral Therapy for Chronic Hepatitis C (2016) (55)
MicroRNAs in hepatic pathophysiology (2017) (55)
Interferon‐gamma–mediated tissue factor expression contributes to T‐cell‐mediated hepatitis through induction of hypercoagulation in mice (2013) (54)
Inhibition of fibroblast to myofibroblast transition by halofuginone contributes to the chemotherapy-mediated antitumoral effect (2007) (54)
Coffee consumption and reduced risk of hepatocellular carcinoma among patients with chronic type C liver disease: A case-control study. (2006) (52)
MiR-29a Assists in Preventing the Activation of Human Stellate Cells and Promotes Recovery From Liver Fibrosis in Mice. (2016) (52)
Cytoglobin is expressed in hepatic stellate cells, but not in myofibroblasts, in normal and fibrotic human liver (2014) (50)
Gene expression during chemically induced liver fibrosis: effect of halofuginone on TGF-β signaling (2007) (50)
Serum Mac‐2 binding protein levels as a novel diagnostic biomarker for prediction of disease severity and nonalcoholic steatohepatitis (2013) (50)
Expression of heat-shock protein 47 in mouse liver (1996) (48)
Hepatitis B virus infection and alcohol consumption (2017) (48)
Macrophage scavenger receptor down-regulates mycobacterial cord factor-induced proinflammatory cytokine production by alveolar and hepatic macrophages. (2006) (47)
Effect of adrenomedullin on hepatic pericytes (stellate cells) of the rat (1994) (47)
Inhibition of Pancreatic Stellate Cell Activation by Halofuginone Prevents Pancreatic Xenograft Tumor Development (2010) (47)
A randomized pilot trial of oral branched‐chain amino acids in early cirrhosis: Validation using prognostic markers for pre–liver transplant status (2009) (46)
Cytoglobin deficiency promotes liver cancer development from hepatosteatosis through activation of the oxidative stress pathway. (2015) (45)
Expression of SPARC by activated hepatic stellate cells and its correlation with the stages of fibrogenesis in human chronic hepatitis (2002) (45)
Expression of cyclins D1, D2 and E correlates with proliferation of rat stellate cells in culture. (1999) (44)
Impaired liver regeneration in mice by lipopolysaccharide via TNF-alpha/kallikrein-mediated activation of latent TGF-beta. (2002) (44)
Regulation of Cell Growth by Redox-mediated Extracellular Proteolysis of Platelet-derived Growth Factor Receptor β* (2001) (44)
The Prevalence and Implication of Zinc Deficiency in Patients With Chronic Liver Disease (2018) (44)
A human-type nonalcoholic steatohepatitis model with advanced fibrosis in rabbits. (2010) (42)
Kupffer cell-mediated recruitment of rat dendritic cells to the liver: roles of N-acetylgalactosamine-specific sugar receptors. (2001) (42)
Applicability of BARD score to Japanese patients with NAFLD (2009) (41)
Noninvasive laboratory tests proposed for predicting cirrhosis in patients with chronic hepatitis C are also useful in patients with non-alcoholic steatohepatitis (2009) (41)
Expression of cellular prion protein in activated hepatic stellate cells. (1998) (40)
The impact of hepatitis C virus outside the liver: Evidence from Asia (2017) (40)
Virological Escape in HCV Genotype-1-Infected Patients Receiving Daclatasvir plus Ribavirin and Peginterferon Alfa-2A or Alfa-2B (2014) (39)
Characterization of human stellate cell activation-associated protein and its expression in human liver. (2002) (38)
Regulation by cAMP of STAT1 activation in hepatic stellate cells. (1997) (38)
Typing of hepatic nonparenchymal cells using fibulin-2 and cytoglobin/STAP as liver fibrogenesis-related markers (2004) (38)
Absence of cytoglobin promotes multiple organ abnormalities in aged mice (2016) (37)
Gene expression during chemically induced liver fibrosis: effect of halofuginone on TGF-beta signaling. (2007) (37)
Expression of Connective Tissue Growth Factor in the Human Liver with Idiopathic Portal Hypertension (2007) (36)
Gene expression profiles of hepatic cell-type specific marker genes in progression of liver fibrosis. (2006) (35)
Use of Mac‐2 binding protein as a biomarker for nonalcoholic fatty liver disease diagnosis (2017) (35)
Clinical significance of circulating soluble immune checkpoint proteins in sorafenib-treated patients with advanced hepatocellular carcinoma (2020) (34)
Human hepatic stellate cells are resistant to apoptosis: implications for human fibrogenic liver disease (2005) (34)
The Alcohol Use Disorders Identification Test for Consumption (AUDIT-C) is more useful than pre-existing laboratory tests for predicting hazardous drinking: a cross-sectional study (2016) (33)
A Clinical Quantitative Evaluation of Hepatobiliary Transport of [11C]Dehydropravastatin in Humans Using Positron Emission Tomography (2018) (33)
Identification of vitamin A-free cells in a stellate cell-enriched fraction of normal rat liver as myofibroblasts (2007) (33)
Nutritional status in relation to lifestyle in patients with compensated viral cirrhosis. (2012) (33)
Daclatasvir Combined with Peginterferon Alfa-2A and Ribavirin in Japanese Patients Infected with Hepatitis C Genotype 1 (2014) (32)
Frequent detection of hepatitis B virus DNA in hepatocellular carcinoma of patients with sustained virologic response for hepatitis C virus (2009) (32)
High-resolution structure of human cytoglobin: identification of extra N- and C-termini and a new dimerization mode. (2006) (32)
Low incidence of hepatitis B virus reactivation and subsequent hepatitis in patients with chronic hepatitis C receiving direct‐acting antiviral therapy (2018) (31)
Attenuation of acute and chronic liver injury in rats by iron-deficient diet. (2008) (31)
Expression of large tenascin-C splice variants by hepatic stellate cells/myofibroblasts in chronic hepatitis C. (2007) (31)
Fibrogenesis in alcoholic liver disease. (2014) (31)
Hepatic stellate cell nomenclature. (1996) (30)
Apoptosis of T cells in the hepatic fibrotic tissue of the rat: a possible inducing role of hepatic myofibroblast-like cells (2003) (30)
Smooth muscle alpha-actin expression in rat hepatic stellate cell is regulated by nitric oxide and cGMP production. (1996) (30)
Entecavir to treat hepatitis B-associated cryoglobulinemic vasculitis. (2008) (29)
Mutational patterns of hepatitis B virus genome and clinical outcomes after emergence of drug‐resistant variants during lamivudine therapy: Analyses of the polymerase gene and full‐length sequences (2007) (28)
N-Acetylglucosaminyltransferase V regulates TGF-β response in hepatic stellate cells and the progression of steatohepatitis. (2012) (28)
Fibroblast growth factor 2 (FGF2) regulates cytoglobin expression and activation of human hepatic stellate cells via JNK signaling (2017) (28)
Ledipasvir‐sofosbuvir for treating Japanese patients with chronic hepatitis C virus genotype 2 infection (2018) (28)
Fascin, a novel marker of human hepatic stellate cells, may regulate their proliferation, migration, and collagen gene expression through the FAK-PI3K-Akt pathway (2012) (27)
HLA class II associated with outcomes of hepatitis B and C infections. (2013) (27)
Rho kinases regulate endothelial invasion and migration during valvuloseptal endocardial cushion tissue formation (2006) (27)
Polymorphisms in MICA, but not in DEPDC5, HCP5 or PNPLA3, are associated with chronic hepatitis C-related hepatocellular carcinoma (2017) (27)
Noninvasive assessment of liver fibrosis in patients with chronic hepatitis B. (2014) (26)
Carbenoxolone inhibits DNA synthesis and collagen gene expression in rat hepatic stellate cells in culture. (2003) (26)
Sofosbuvir plus velpatasvir treatment for hepatitis C virus in patients with decompensated cirrhosis: a Japanese real-world multicenter study (2020) (25)
Interferon gamma modulates production of interleukin 1 and tumor necrosis factor by murine Kupffer cells. (2008) (25)
Targeted and regulable expression of transgenes in hepatic stellate cells and myofibroblasts in culture and in vivo using an adenoviral Cre/loxP system to antagonise hepatic fibrosis (2006) (24)
Apoptosis: A new mechanism of endothelial and Kupffer cell killing (1995) (24)
Induction of tropomyosin during hepatic stellate cell activation and the progression of liver fibrosis (2009) (24)
Regulation of cultured rat hepatocyte proliferation by stellate cells. (2002) (24)
Short-term histological evaluations after achieving a sustained virologic response to direct-acting antiviral treatment for chronic hepatitis C (2018) (24)
Nucleotide receptors in hepatic stellate cells of the rat (1994) (24)
Two cases of hepatocellular adenomatosis treated with transcatheter arterial embolization (2009) (23)
Benefits of artificially induced pleural effusion and/or ascites for percutaneous radiofrequency ablation of hepatocellular carcinoma located on the liver surface and in the hepatic dome. (2012) (22)
Prospective long‐term study of hepatitis B virus reactivation in patients with hematologic malignancy (2014) (22)
Outcomes of laparoscopic hepatic resection versus percutaneous radiofrequency ablation for hepatocellular carcinoma located at the liver surface: A case–control study with propensity score matching (2016) (22)
High Prevalence of Gastroesophageal Reflux Symptoms in Patients with Non-Alcoholic Fatty Liver Disease Associated with Serum Levels of Triglyceride and Cholesterol but Not Simple Visceral Obesity (2012) (22)
Possible Involvement of Nitric Oxide in Enhanced Liver Injury and Fibrogenesis during Cholestasis in Cytoglobin-deficient Mice (2017) (22)
Clinical course of COVID-19 in patients with pre-existing decompensated cirrhosis: initial report from China (2020) (22)
Combination therapy with a nucleos(t)ide analogue and interferon for chronic hepatitis B: simultaneous or sequential (2013) (22)
Entecavir and interferon-α sequential therapy in Japanese patients with hepatitis B e antigen-positive chronic hepatitis B (2013) (22)
Phosphorylated Smad2 and Smad3 signaling: Shifting between tumor suppression and fibro‐carcinogenesis in chronic hepatitis C (2013) (21)
Electrophysiological characterization of cultured hepatic stellate cells in rats. (1997) (21)
Intention‐to‐treat assessment of glecaprevir + pibrentasvir combination therapy for patients with chronic hepatitis C in the real world (2019) (21)
Calcium-dependent prostaglandin biosynthesis by lipopolysaccharide-stimulated rat Kupffer cells. (1992) (21)
Effect of natural interferon α on proliferation and apoptosis of hepatic stellate cells (2009) (21)
Effects of arachidonic acid metabolites and interleukin‐1 on platelet activating factor production by hepatic sinusoidal endothelial cells from mice (1991) (20)
Clinicopathological characterization of prion: a novel marker of activated human hepatic stellate cells. (2000) (20)
Morphological study of endothelin-1-induced contraction of cultured hepatic stellate cells on hydrated collagen gels (1996) (19)
Cytoglobin as a Marker of Hepatic Stellate Cell-derived Myofibroblasts (2015) (19)
The Hemoglobin Homolog Cytoglobin in Smooth Muscle Inhibits Apoptosis and Regulates Vascular Remodeling (2017) (19)
Inhibition of myofibroblastic transformation of cultured rat hepatic stellate cells by methylxanthines and dibutyryl cAMP (1996) (19)
Effects of antiviral therapy in patients with chronic hepatitis B and cirrhosis (2017) (19)
Proteome Characteristics of Non-Alcoholic Steatohepatitis Liver Tissue and Associated Hepatocellular Carcinomas (2017) (19)
The hepatic stellate cell in the post-genomic era. (2002) (18)
Epiregulin stimulates proliferation of rabbit gastric cells in primary culture through autophosphorylation of the epidermal growth factor receptor. (1997) (18)
The anti-oxidative role of cytoglobin in podocytes: implications for a role in chronic kidney disease. (2020) (18)
Hepatic expression of c‐Myb in chronic human liver disease (1997) (18)
Clinical Outcomes in Biopsy-Proven Nonalcoholic Fatty Liver Disease Patients: A Multicenter Registry-Based Cohort Study. (2022) (18)
Expression of cytochrome P450 isoforms in rat hepatic stellate cells. (1997) (17)
Inhibition of the activation of hepatic stellate cells by arundic acid via the induction of cytoglobin. (2012) (17)
Differences in molecular alterations of hepatocellular carcinoma between patients with a sustained virological response and those with hepatitis C virus infection (2009) (17)
Sulfur-containing amino acids attenuate the development of liver fibrosis in rats through down-regulation of stellate cell activation. (2004) (17)
Circulating Exosomal miRNA Profiles Predict the Occurrence and Recurrence of Hepatocellular Carcinoma in Patients with Direct-Acting Antiviral-Induced Sustained Viral Response (2019) (17)
Effect of Mosapride Citrate on Gastric Emptying in Interferon-Induced Gastroparesis (2012) (16)
Immunohistochemical characterization of cancer-associated fibroblasts at the primary sites and in the metastatic lymph nodes of human intrahepatic cholangiocarcinoma. (2019) (16)
Close correlation of liver stiffness with collagen deposition and presence of myofibroblasts in non‐alcoholic fatty liver disease (2011) (16)
Changes in leukotrienes and prostaglandins in the liver tissue of rats in the experimental massive hepatic cell necrosis model. (1990) (16)
Retinoic acid-stimulated liver stellate cells suppress the production of albumin from parenchymal cells via TGF-beta. (1996) (16)
Selective overexpression of cytoglobin in stellate cells attenuates thioacetamide-induced liver fibrosis in mice (2018) (16)
Role of oxidative stress and Kupffer cells in hepatic fibrosis (2007) (16)
Long-Term Prognostic Factors after Hepatic Resection for Hepatitis C Virus-Related Hepatocellular Carcinoma, with a Special Reference to Viral Status (2018) (16)
Involvement of hepatic stellate cell cytoglobin in acute hepatocyte damage through the regulation of CYP2E1-mediated xenobiotic metabolism (2015) (15)
Obesity and hiatal hernia may be non-allergic risk factors for esophageal eosinophilia in Japanese adults (2019) (15)
Thioredoxin prevents thioacetamide-induced acute hepatitis (2004) (15)
Noninvasive Diagnosis of Liver Fibrosis: Utility of Data Mining of Both Ultrasound Elastography and Serological Findings to Construct a Decision Tree (2014) (15)
Prediction for Improvement of Liver Function after Balloon-Occluded Retrograde Transvenous Obliteration for Gastric Varices to Manage Portosystemic Shunt Syndrome. (2016) (15)
Thiopurine S‐methyltransferase gene polymorphism in Japanese patients with autoimmune liver diseases (2007) (15)
A case of sclerosing cholangitis with autoimmune pancreatitis evaluated by FDG-PET (2007) (15)
Effect of S-adenosyl-L-methionine on the activation, proliferation and contraction of hepatic stellate cells. (2005) (15)
MicroRNA expression in hepatocellular carcinoma after the eradication of chronic hepatitis virus C infection using interferon therapy (2016) (15)
Discovery of cytoglobin and its roles in physiology and pathology of hepatic stellate cells (2016) (15)
Relationship between inosine triphosphate genotype and outcome of extended therapy in hepatitis C virus patients with a late viral response to pegylated‐interferon and ribavirin (2014) (15)
Mechanism that regulates nitric oxide production by lipopolysaccharide-stimulated rat Kupffer cells. (1996) (15)
Pepstatin A attenuates the inhibitory effect of N-acetyl-L-cysteine on proliferation of hepatic myofibroblasts (stellate cells). (2002) (14)
Does alcohol increase the risk of hepatocellular carcinoma among patients with hepatitis C virus infection? (2006) (14)
Positioning of 18F‐fluorodeoxyglucose‐positron emission tomography imaging in the management algorithm of hepatocellular carcinoma (2014) (14)
Possible induction of fatty acid cyclo-oxygenase in lipopolysaccharide-stimulated rat Kupffer cells. (1992) (14)
Rho kinase inhibitor Y27632 affects initial heart myofibrillogenesis in cultured chick blastoderm (2007) (14)
Effect of gomisin A in the prevention of acute hepatic failure induction. (1991) (14)
Anti-fibrotic treatments for chronic liver diseases: The present and the future (2020) (14)
Putting “sticky notes” on the electronic medical record to promote intra-hospital referral of hepatitis B and C virus-positive patients to hepatology specialists: an exploratory study (2016) (13)
Focal nodular hyperplasia-like lesion with venous washout in alcoholic liver cirrhosis. (2008) (13)
Clinical significance of pretreatment serum interferon‐gamma‐inducible protein 10 concentrations in chronic hepatitis C patients treated with telaprevir‐based triple therapy (2014) (13)
Emerging antiviral drugs for hepatitis C virus. (2009) (13)
A complete response induced by 21-day sorafenib therapy in a patient with advanced hepatocellular carcinoma. (2013) (13)
Stagnation of histopathological improvement is a predictor of hepatocellular carcinoma development after hepatitis C virus eradication (2018) (13)
Maintenance of hepatocyte functions in coculture with hepatic stellate cells (2004) (13)
Immunohistochemical detection of Fas and apoptosis in type-1 autoimmune hepatitis. (2003) (13)
Cytoglobin expression of rectal subepithelial myofibroblasts: significant alterations of cytoglobin+ stromal cells in long-standing ulcerative colitis. (2011) (12)
Action of endothelins on hepatic stellate cells (1995) (12)
Expression of progenitor cell markers in livers with fulminant massive necrosis. (2003) (12)
Changes in sequences of core region, interferon sensitivity‐determining region and interferon and ribavirin resistance‐determining region of hepatitis C virus genotype 1 during interferon‐alpha and ribavirin therapy, and efficacy of retreatment (2012) (12)
The presence of multiple NS5A RASs is associated with the outcome of sofosbuvir and ledipasvir therapy in NS5A inhibitor‐naïve patients with chronic HCV genotype 1b infection in a real‐world cohort (2018) (12)
Effect of Caffeine-Containing Beverage Consumption on Serum Alanine Aminotransferase Levels in Patients with Chronic Hepatitis C Virus Infection: A Hospital-Based Cohort Study (2013) (12)
Interferon-β plus ribavirin for patients with hepatitis C virus genotype 1: a randomised pilot trial (2005) (12)
Non-invasive diagnosis of liver fibrosis (2011) (12)
Chemiluminescence enzyme immunoassay for monitoring hepatitis C virus core protein during interferon‐α2b and ribavirin therapy in patients with genotype 1 and high viral loads (2005) (12)
Increased 5‐lipoxygenase activity in massive hepatic cell necrosis in the rat correlates with neutrophil infiltration (1992) (11)
Expression of Fas and Bcl-2 proteins and induction of apoptosis in human hepatocellular carcinoma cell lines (1999) (11)
1193 A DESCRIPTION OF VIROLOGIC ESCAPE IN HCV GENOTYPE 1-INFECTED PATIENTS TREATED WITH DACLATASVIR (BMS-790052) IN COMBINATION WITH RIBAVIRIN AND PEGINTERFERON ALFA-2A OR PEGINTERFERON ALFA-2B (2012) (11)
Role of Oxidative and Nitrosative Stress in Hepatic Fibrosis (2017) (11)
Gasdermin D–mediated release of IL-33 from senescent hepatic stellate cells promotes obesity-associated hepatocellular carcinoma (2022) (11)
Characterization of vitamin A-storing cells in mouse fibrous kidneys using Cygb/STAP as a marker of activated stellate cells. (2007) (11)
Lenvatinib-Induced Tumor-Related Hemorrhages in Patients with Large Hepatocellular Carcinomas (2020) (11)
Liver-related events after direct-acting antiviral therapy in patients with hepatitis C virus-associated cirrhosis (2022) (11)
Molecular mechanism of stellate cell activation and therapeutic strategy for liver fibrosis (2004) (11)
Involvement of Galectin-1 and Galectin-3 in Proliferation and Migration of Rat Hepatic Stellate Cells in Culture (2004) (11)
Applicability of APRI and FIB-4 as a transition indicator of liver fibrosis in patients with chronic viral hepatitis (2021) (11)
Role of nitric oxide in extracellular nucleotide-induced contractile status of assorted vessels including parts of the portal vasculature. (1998) (10)
Hexa Histidine–Tagged Recombinant Human Cytoglobin Deactivates Hepatic Stellate Cells and Inhibits Liver Fibrosis by Scavenging Reactive Oxygen Species (2021) (10)
[Drug-induced liver injury caused by an herbal medicine, bofu-tsu-sho-san]. (2008) (10)
Regulation of stellate cell proliferation by lipopolysaccharide: Role of endogenous nitric oxide (1998) (10)
Regulation of stellate cell proliferation by lipopolysaccharide: role of endogenous nitric oxide. (1998) (9)
Association between HLA‐DQA1/DRB1 polymorphism and development of hepatocellular carcinoma during entecavir treatment (2018) (9)
Cancer serum proteomics in gastroenterology. (2006) (9)
Response‐guided therapy for patients with chronic hepatitis who have high viral loads of hepatitis C virus genotype 2 (2012) (9)
Prevalence and risk factors of functional constipation in the Rome IV criteria during a medical check‐up in Japan (2021) (9)
Association between Functional Dyspepsia and Gastric Depressive Erosions in Japanese Subjects (2018) (9)
Development of novel hepatitis B virus capsid inhibitor using in silico screening. (2015) (9)
Interstitial fluid flow-induced growth potential and hyaluronan synthesis of fibroblasts in a fibroblast-populated stretched collagen gel culture. (2017) (9)
Discovering novel direct acting antiviral agents for HBV using in silico screening. (2015) (9)
TGF-β-driven reduction of cytoglobin leads to oxidative DNA damage in stellate cells during non-alcoholic steatohepatitis. (2020) (9)
Lamivudine and IFN-beta sequential therapy in HBe antigen-positive patients with chronic hepatitis B virus genotype C infection. (2007) (9)
Synthesis of eicosanoids by Propionibacterium acnes-elicited liver adherent cells and their effect on production of interleukin 1 and tumor necrosis factor. (1990) (9)
Eosinophilic esophagitis and asymptomatic esophageal eosinophilia display similar immunohistological profiles (2020) (8)
Early Change in the Plasma Levels of Circulating Soluble Immune Checkpoint Proteins in Patients with Unresectable Hepatocellular Carcinoma Treated by Lenvatinib or Transcatheter Arterial Chemoembolization (2020) (8)
Outcomes of Sequential Therapy With Tenofovir Alafenamide After Long-term Entecavir. (2021) (8)
Correlation between polymorphism in the inosine triphosphatase and the reductions in hemoglobin concentration and ribavirin dose during sofosbuvir and ribavirin therapy (2017) (8)
Establishment and characteristics of human hepatocellular carcinoma cells with metastasis to lymph nodes. (1999) (8)
A case of primary small cell carcinoma of the liver that was treated with chemotherapy (2008) (8)
Randomized trial of combined triple therapy comprising two types of peginterferon with simeprevir in patients with hepatitis C virus genotype 1b (2016) (8)
Clinical role of FDG-PET for HCC: relationship of glucose metabolic indicator to Japan Integrated Staging (JIS) score. (2008) (8)
Outcomes for Cirrhotic Patients with Hepatitis C Virus 1b Treated with Asunaprevir and Daclatasvir Combination. (2017) (8)
Usefulness of a New Immunoradiometric Assay of HCV Core Antigen to Predict Virological Response during PEG-IFN/RBV Combination Therapy for Chronic Hepatitis with High Viral Load of Serum HCV RNA Genotype 1b (2008) (8)
Arachidonate metabolism in D-galactosamine or carbon tetrachloride-induced acute and chronic liver injuries in rats (1992) (7)
Regression of portal hypertension: underlying mechanisms and therapeutic strategies (2021) (7)
Effect of glycyrrhizin and glycyrrhetinic acid on arachidonic acid metabolism in peritoneal exudate cells of rat. (1989) (7)
Arachidonic acid metabolites in carbon tetrachloride-induced liver injury (1990) (7)
A validation study of the Ursodeoxycholic Acid Response Score in Japanese patients with primary biliary cholangitis (2020) (7)
Involvement of ERK1/2 activation in the gene expression of senescence-associated secretory factors in human hepatic stellate cells (2018) (7)
Heterogeneous liver uptake of Tc-99m-GSA as quantified through SPECT/CT helps to evaluate the degree of liver fibrosis (2018) (7)
Interferon-β Mediates Signaling Pathways Uniquely Regulated in Hepatic Stellate Cells and Attenuates the Progression of Hepatic Fibrosis in a Dietary Mouse Model. (2015) (7)
Interstitial pneumonia suspected during regorafenib administration and exacerbated by subsequent therapy with lenvatinib for unresectable hepatocellular carcinoma (2019) (7)
Optimal duration of additional therapy after biochemical and virological responses to lamivudine in patients with HBeAg‐negative chronic hepatitis B: a randomized trial (2008) (7)
Switching to tenofovir disoproxil fumarate vs continuing treatment in patients with chronic hepatitis B who maintain long‐term virological response to entecavir therapy: A randomized trial (2019) (7)
Significant role of apoptosis in type-1 autoimmune hepatitis. (1999) (7)
Sildenafil-Induced Severe Cholestatic Hepatotoxicity (2009) (7)
Primary localized cutaneous amyloidosis associated with autoimmune cholangitis (2000) (6)
Cytoglobin May Be Involved in the Healing Process of Gastric Mucosal Injuries in the Late Phase Without Angiogenesis (2013) (6)
Development of a novel anti-hepatitis B virus agent via Sp1 (2020) (6)
Enhancement of prostaglandin E2 production by liver macrophages (Kupffer cells) after stimulation with biological response modifiers. (1992) (6)
Twelve weeks of ledipasvir/sofosbuvir all‐oral regimen for patients with chronic hepatitis C genotype 2 infection: Integrated analysis of three clinical trials (2020) (6)
High prevalence of hepatitis C virus infection in Airin district, Osaka, Japan: A hospital‐based study of 1162 patients (2011) (6)
Role of cytoglobin, a novel radical scavenger, in stellate cell activation and hepatic fibrosis (2020) (6)
Pancreatic Cancer Cell Fraction Estimation in a DNA Sample (2018) (6)
Immunohistochemical and ultrastructural analyses of in situ activation of hepatic stellate cells around Propionibacterium acnes-induced granulomas in the rat liver. (1997) (6)
Surgical Outcomes in Hepatitis C Virus-Related Hepatocellular Carcinoma: Special Reference to Sustained Virological Responses to Interferon Therapy (2017) (5)
Suppression of Rat Stellate Cell Activation and Liver Fibrosis by a Japanese Herbal Medicine, Inchinko-to (TJ135) (2004) (5)
The Moral of Hepatic Fibrosis: Don’t Always Believe Noninvasive Fibrosis Measurements (2020) (5)
Long-Term Follow-Up of Resistance-Associated Substitutions in Hepatitis C Virus in Patients in Which Direct Acting Antiviral-Based Therapy Failed (2017) (5)
Interactions of Stellate Cells with Other Non-Parenchymal Cells (2015) (5)
Stress can attenuate hepatic lipid accumulation via elevation of hepatic β-muricholic acid levels in mice with nonalcoholic steatohepatitis (2020) (5)
Tolerance and acceptance of hepatic venous pressure gradient measurement in cirrhosis (CHESS1904): An international multicenter study (2022) (5)
Extracellular nucleotides modulate the portal circulation with generation of nitric oxide (1998) (5)
Pathophysiological role of cytoglobin, the fourth globin in mammals, in liver diseases. (2016) (5)
Sequential therapy involving an early switch from entecavir to pegylated interferon‐α in Japanese patients with chronic hepatitis B (2018) (5)
Remission of Psoriasis After Treatment of Chronic Hepatitis C Virus Infection With Direct-Acting Antivirals (2018) (5)
Effects on anemia of drug adjustment in patients with chronic hepatitis C during telaprevir-combined therapy. (2015) (5)
Analysis of proteins dominantly expressed in hepatic stellate cells of activated phenotype. (2005) (5)
Surgical outcomes for hepatocellular carcinoma detected after hepatitis C virus eradiation by direct‐acting antivirals (2020) (5)
Synthesis of interleukin 1 by liver adherent cells of Kupffer cells and its regulation with prostaglandin. (1989) (5)
Injection Site with Generalized Rash Caused by Pegylated Interferon Alpha 2a Injection (2005) (5)
Lifestyle changes during the coronavirus disease 2019 pandemic impact metabolic dysfunction–associated fatty liver disease (2022) (5)
Changes in plasma interleukin-8 and tumor necrosis factor-α levels during the early treatment period as a predictor of the response to sorafenib in patients with unresectable hepatocellular carcinoma (2018) (5)
The FibroScan-aspartate aminotransferase score can stratify the disease severity in a Japanese cohort with fatty liver diseases (2021) (5)
Development of non-invasive method for assessment of hepatic steatosis. (2016) (5)
Distinct responsiveness to rifaximin in patients with hepatic encephalopathy depends on functional gut microbial species (2022) (5)
Serum Mac-2-binding protein glycosylation isomer predicts esophagogastric varices in cirrhotic patients with chronic hepatitis C virus infection treated with IFN-free direct-acting antiviral agent: M2BPGi levels predict varices in SVR patients. (2020) (4)
Environmental factors, medical and family history, and comorbidities associated with primary biliary cholangitis in Japan: a multicenter case–control study (2021) (4)
Utility of Kyoto Classification of Gastritis in subjects with a high-negative titer of anti-Helicobacter pylori antibody during a medical check-up (2020) (4)
Does a late evening meal reduce the risk of hepatocellular carcinoma among patients with chronic hepatitis C? (2008) (4)
Long-Term Outcome of Sequential Therapy with Lamivudine Followed by Interferon-β in Nucleoside-Naive, Hepatitis B e-Antigen-Positive Patients with Chronic Hepatitis B Virus Genotype C Infection. (2015) (4)
Promotion of intra-hospital referral of hepatitis B and C virus carriers to hepatology specialists by electronic medical record-based alert system: a case study at a university hospital (2016) (4)
Favorable factors for re‐treatment with pegylated interferon α2a plus ribavirin in patients with high viral loads of genotype 1 hepatitis C virus (2011) (4)
Exosomal hsa-miR-933 in Gastric Juice as a Potential Biomarker for Functional Dyspepsia (2020) (4)
Clinical course and risk factors for mortality of COVID-19 patients with pre-existing cirrhosis: A multicenter cohort study (2020) (4)
Postoperative direct‐acting antiviral treatment after liver resection in patients with hepatitis C virus‐related hepatocellular carcinoma (2021) (4)
[Current situation and future prospect of cytoglobin research]. (2013) (4)
Treatment guidelines for HCV genotype 1: mono for low, triple for high, and dual for ‘middle’? (2013) (3)
[Rabbit model for the study of human NASH]. (2006) (3)
The expression level of miR-18b in hepatocellular carcinoma is associated with the grade of malignancy and prognosis (2013) (3)
Post-Treatment M2BPGi Level and the Rate of Autotaxin Reduction are Predictive of Hepatocellular Carcinoma Development after Antiviral Therapy in Patients with Chronic Hepatitis C (2020) (3)
[Detection of leukotrienes in rat liver tissue]. (1988) (3)
[Release of peptide leukotrienes from rat Kupffer cells]. (1988) (3)
Interferon γ stimulates prostaglandin E2 production by mouse Kupffer cells (1990) (3)
Utility of minimally invasive measurement of hepatic venous pressure gradient via the peripheral antecubital vein (2020) (3)
Serotonin and tryptamine metabolism in the acute hepatic failure model: changes in tryptophan and its metabolites in the liver, brain and kidney. (1989) (3)
Interferon‐α/β for treatment of chronic hepatitis C infection in the era of direct‐acting antiviral agents (2014) (3)
Lenvatinib-Induced Tumor-Related Hemorrhage in Patients With Unresectable Hepatocellular Carcinoma. (2020) (3)
Combination therapy of natural human interferon‐beta and ribavirin for chronic hepatitis C patients with injection drug use (2013) (3)
Combination of Entecavir or Tenofovir with Pegylated Interferon-α for Long-Term Reduction in Hepatitis B Surface Antigen Levels: Simultaneous, Sequential, or Add-on Combination Therapy (2021) (3)
Characterization of arachidonate 12-lipoxygenase found in the liver of mongrel dog and its immunohistochemical localization in neutrophils. (1995) (3)
[Effects of magnesium lithospermate B on cyclooxygenase activity in rat liver, adherent cells and enzyme's product]. (1994) (3)
New player in tumor‐stromal interaction: Granulin as a novel therapeutic target for pancreatic ductal adenocarcinoma liver metastasis (2017) (3)
The protective effects of Sho-saiko-to in an experimental, immunologically-induced allergic hepatic cell injury (1990) (3)
Platelet‐associated IgG for the diagnosis of immune thrombocytopaenic purpura during peginterferon α and ribavirin treatment for chronic hepatitis C (2008) (3)
Association of serum autotaxin levels with liver fibrosis in patients pretreatment and posttreatment with chronic hepatitis C (2020) (3)
Soluble programmed cell death-1 predicts hepatocellular carcinoma development during nucleoside analogue treatment (2021) (3)
Outcome of nucleos(t)ide analog intervention in patients with preventive or on‐demand therapy for hepatitis B virus reactivation (2020) (3)
A pregnant woman with acute hepatitis B in whom vertical transmission was prevented by tenofovir disoproxil fumarate (2013) (2)
Genome-Wide Association Study Identi fi es TLL 1 Variant Associated With Development of Hepatocellular Carcinoma After Eradication of Hepatitis C Virus Infection (2017) (2)
Destructive thyroiditis presenting as thyrotoxicosis followed by hypothyroidism during lenvatinib therapy for hepatocellular carcinoma (2020) (2)
The Administration of Tenofovir Disoproxil Fumarate for Pregnant Japanese Women with Chronic Hepatitis B (2020) (2)
Could Trastuzumab Suppress Hepatitis C Virus in a Patient With Chronic Hepatitis and Breast Cancer? (2011) (2)
Successful Transcatheter Arterial Embolization for Hemothorax from a Spontaneous Rupture of Hepatocellular Carcinoma Metastasis to the Chest Wall in an Elderly Patient (2021) (2)
Cancer cells produce liver metastasis via gap formation in sinusoidal endothelial cells through proinflammatory paracrine mechanisms (2022) (2)
Direct‐acting antivirals reduce the risk of tumour progression of hepatocellular carcinoma after curative treatment (2021) (2)
Antifibrotic role of macrophage migration inhibitory factor: Discovery of an unexpected function (2012) (2)
The effect of lipo-prostaglandin E1 on the production of interleukin 1 and platelet-activating factor by hepatic sinusoidal endothelial cells in mice. (1991) (2)
Risk factors for hepatocellular carcinoma in treated chronic hepatitis C patients–Relationship to smoking and alcohol (2020) (2)
High resolution structure of cytoglobin reveals the extra helix in N-terminus (2005) (2)
The Alcohol Use Disorders. Identification Test (AUDIT) score is useful for predicting alcohol consumption. (2016) (2)
[Tumor lysis syndrome after transarterial embolization for hepatocellular carcinoma]. (2013) (2)
A novel noninvasive formula for predicting cirrhosis in patients with chronic hepatitis C (2021) (2)
Interferon gamma stimulates prostaglandin E2 production by mouse Kupffer cells. (1990) (2)
The Albumin-bilirubin Score Detects Changes in the Liver Function during Treatment for Budd-Chiari Syndrome: A Retrospective Observational Study (2021) (2)
P3-17 Expression of STAP (stellate cell activation-associated protein) in the visceral fibroblasts of rats (2002) (2)
Sofosbuvir/Velpatasvir Plus Ribavirin Combination Therapy for Patients with Hepatitis C Virus Genotype 1a, 2a, or 3b after Glecaprevir/Pibrentasvir Therapy Failed (2021) (2)
Effects of arachidonic acid metabolites and platelet-activating factor(PAF) on interleukin-1 synthesis from mouse hepatic sinusoidal endothelium. (1990) (2)
Hepatitis C virus recurrence in two patients who achieved sustained viral response with interferon-free direct-acting antiviral therapy: reinfection or relapse? (2019) (2)
Precancerous Lesions and Liver Atrophy as Risk Factors for Hepatolithiasis-Related Death after Liver Resection for Hepatolithiasis (2020) (2)
Retinoids and Liver Fibrosis (1999) (2)
Control of HCV Replication With iMIRs, a Novel Anti-RNAi Agent (2015) (2)
Cytoglobin attenuates pancreatic cancer growth via scavenging reactive oxygen species (2022) (2)
TRANSFUSION-TRANSMITTED HBV INFECTION DETECTED BY LOOKBACK STUDY FOR BLOOD DONOR-A CASE REPORT (2008) (2)
Plasma xanthine oxidoreductase activity change over 12 months independently associated with change in serum uric acid level: MedCity21 health examination registry (2020) (2)
Validation of a two‐step approach combining serum biomarkers and liver stiffness measurement to predict advanced fibrosis (2021) (1)
410 USEFULNESS OF REAL-TIME TISSUE ELASTOGRAPHY FOR NONINVASIVE ASSESSMENT OF LIVER STIFFNESS IN PATIENTS WITH CHRONIC HEPATITIS C: VERSUS TRANSIENT ELASTOGRAPHY (FIBROSCAN) (2010) (1)
Prognostic Nutrition Index as an Indicator of Therapeutic Response to Lenvatinib Therapy in Hepatocellular Carcinoma (2022) (1)
High dropout rate from aftercare program of antihepatitis C therapy for patients with history of injection drug use (2020) (1)
Short Communication Expression of Cellular Prion Protein in Activated Hepatic Stellate Cells (1998) (1)
931 EXPRESSION OF PERILIPIN AND ADIPOPHILIN IN HUMAN NONALCOHOLIC FATTY LIVER DISEASE AND THEIR RELATION TO OXIDATIVE DAMAGE (2008) (1)
[Liver fibrosis--the forefront of the study on stellate cells]. (2001) (1)
Hepatitis B-associated cryoglobulinemia and antiphospholipid antibodies (2010) (1)
Handling of Activation Status of Human Hepatic Stellate Cells by Low-Molecular-Weight FGF2 via the Induction of Cytoglobin (2016) (1)
Cytoglobin-expressing cells in the splenic cords contribute to splenic fibrosis in cirrhotic patients. (2020) (1)
Anti‐hepatitis B virus therapy: To stop, or not to stop: Has the question been solved? (2012) (1)
A case of autoimmune hepatitis showing resistance to a steroid and immunosuppressants (2009) (1)
Obstructive Jaundice Due to Duodenal Ulcer Induced by Lenvatinib Therapy for Hepatocellular Carcinoma (2020) (1)
Detection of HCV RNA in Sustained Virologic Response to Direct-Acting Antiviral Agents: Occult or Science Fiction? (2017) (1)
A multicenter, retrospective, cohort study shows platelet counts predict HCC development in patients with NAFLD. (2023) (1)
The Current Status of Non-Invasive Assessment of Liver Fibrosis: Real Time Tissue Elastography (2011) (1)
A case series of five patients with hepatic sarcoidosis diagnosed by liver biopsy (2019) (1)
Nitric Oxide Derived from Cytoglobin-Deficient Hepatic Stellate Cells Causes Suppression of Cytochrome c Oxidase Activity in Hepatocytes (2022) (1)
[Serotonin and tryptamine metabolism in the acute hepatic failure model--changes in tryptophan and its metabolites in the liver, brain, kidney and serum]. (1990) (1)
A case of hepatitis C virus-associated mixed cryoglobulinemic vasculitis treated with daclatasvir and asunaprevir (2016) (1)
LPS-INDUCED APOPTOSIS IN KUPFFER CELLS (1995) (1)
Network of cytokine and arachidonic acid cascade in acute hepatic failure (1993) (1)
Activated Kupffer cells induce apoptosis in sinusoidal endothelial cells by juxtacrine mechanism (1994) (1)
Response-Guided Peginterferon α-2a Monotherapy for Hemodialysis Patients with Chronic Hepatitis C (2014) (1)
[The protective effects of glucagon and insulin in an experimental massive hepatic cell necrosis model]. (1990) (1)
Mature Peritoneal Macrophages Take an Avascular Route Into the Injured Liver and Promote Tissue Repair (2016) (1)
Methylated SEPT9 assay-based liquid biopsy as a biomarker in molecular targeted agent-treated hepatocellular carcinoma (2023) (1)
Cloaking the ACE2 receptor with salivary cationic proteins inhibits SARS-CoV-2 entry (2022) (1)
Lenvatinib-Induced Tumor-Related Hemorrhage in Patients With Unresectable Hepatocellular Carcinoma. (2021) (1)
Capacity of extracellular globins to reduce liver fibrosis via scavenging reactive oxygen species and promoting MMP-1 secretion (2022) (1)
Half-Moon-shaped Aortic Arch Thrombosis Induced by Lenvatinib. (2021) (1)
292 A RANDOMIZED PILOT TRIAL OF ORAL BRANCHED-CHAIN AMINO ACIDS IN EARLY LIVER CIRRHOSIS (2008) (1)
Regulation of stellate cell growth by redox-mediated extracellular proteolysis of platelet-derived growth factor receptor-B (2002) (1)
Pathophysiology of acute obstructive cholangitis (1996) (1)
Soluble Immune Checkpoint Protein CD27 Is a Novel Prognostic Biomarker of Hepatocellular Carcinoma Development in Hepatitis C Virus–Sustained Virological Response Patients (2022) (1)
A case of drug-induced pneumonitis caused by transcatheter arterial infusion with miriplatin for hepatocellular carcinoma (2012) (1)
Review The hepatic stellate cell in the post-genomic era (2002) (1)
Effect of cepharanthine on metabolism of arachidonic acid from rat peritoneal exudate cells. (1988) (1)
THU-183-Prospective multicenter study of glecaprevir plus pibrentasvir combination therapy for patients with chronic hepatitis C (2019) (1)
Fatty change in human hepatocellular carcinoma cell lines derived from patients with antibodies to hepatitis C virus. (2002) (1)
A case of hepatocellular carcinoma successfully treated by percutaneous radiofrequency ablation using the laparoscopic artificial ascites technique (2007) (0)
Effect of adrenomedullin, a novel vasoactive peptide, on hepatic pericytes (stellate cells) of the rat (1995) (0)
The safety and efficacy of hepatic arterial infusion chemotherapy with cisplatin. (2018) (0)
Identification of gut bacterial candidates involved in hepatic encephalopathy by the analysis of feces DNA from patients administered rifaximin (2020) (0)
Immunohistochemical study on collagen producing cells in pancreas (2016) (0)
Repeat lung cancer screenings reveal less CXR abnormalities with different variations than first-time screening (2021) (0)
[Latest anti-fibrotic therapies for chronic liver diseases]. (2020) (0)
Soluble immune checkpoint protein CD27 is a novel prognostic biomarker of HCC development in HCV-SVR patients. (2022) (0)
[Drug-induced hepatitis]. (1995) (0)
P3-252Current Status and Perspective of Call Request in Lung Cancer Screening (2017) (0)
[Sequential therapy with a nucleos(t)ide analogue and interferon in patients with chronic hepatitis B: efficacy and limitations]. (2011) (0)
Effects of irsoglandine maleate in an experimentally-induced acute hepatic failure model using mice (1991) (0)
Involvement of ERK1/2 activation in the gene expression of senescence-associated secretory factors in human hepatic stellate cells (2018) (0)
P1050 LONG-TERM OUTCOME OF SEQUENTIAL THERAPY WITH LAMIVUDINE FOLLOWED BY INTERFERON IN NUCLEOSIDE-NAIVE, HEPATITIS B E ANTIGEN-POSITIVE PATIENTS WITH CHRONIC HEPATITIS B VIRUS GENOTYPE C INFECTION (2014) (0)
Identification of FGF2 as a cytoglobin regulatory factor leading to the deactivation of human hepatic stellate cells (2015) (0)
II. Molecular Mechanism of Liver Fibrosis and the Markers in Blood (2022) (0)
Function of nitric oxide in and around hepatic sinusoids (1994) (0)
Soluble programmed cell death-1 predicts hepatocellular carcinoma development during nucleoside analogue treatment (2022) (0)
Amino acids, L-Cysteine and L-Methionine, Attenuate Activation of Rat Stellate Cells in Primary Culture (2004) (0)
315 PDGF receptor as a molecular target of antioxidants in stellate cell (2004) (0)
Characterization of cancer associated fibroblasts in primary site and metaststic lymph nodes of intrahepatic cholangiocarcinoma by immunohistochmistry (2017) (0)
Antioxidant Approach to the Therapy of Chronic Liver Diseases (2015) (0)
Rat stellate cells regulate proliferation of rat hepatocytes in culture (2002) (0)
Hydrophobic Residues Regulate Distal Histidine Coordinations in Human Cgb and Ngb (2010) (0)
SPECIFIC SUPPRESSION OF TNF-?? PRODUCTION FROM ACTIVATED KUPFFER CELLS BY ANTISENSE DNA OLIGOMERS (1995) (0)
Acute renal failure - basic research (2009) (0)
Pancreatic cancer biomarkers among exosome-fractionated circulating miRNAs. (2016) (0)
Efficacy of rechallenge transcatheter arterial chemoembolization after lenvatinib treatment for advanced hepatocellular carcinoma (2022) (0)
PDGF signaling in cell cycle progression of cultured rat hepatic stellate cells. (2000) (0)
Changes in prostaglandins and leukotrienes in the liver tissue of guinea pigs in the experimental massive hepatic cell necrosis model. (1989) (0)
GASTROINTESTINAL , HEPATOBILIARY , AND PANCREATIC PATHOLOGY Cytoglobin De fi ciency Promotes Liver Cancer Development from Hepatosteatosis through Activation of the Oxidative Stress Pathway (0)
The role of nitric oxide of responses to nucleotides in rat hepatic vessels (1994) (0)
[329] DAMAGED ERYTHROCYTES MAY BE ASSOCIATED WITH OXIDATIVE STRESS AND FIBROGENSIS IN A RABBIT MODEL OF STEATOHEPATITIS (2007) (0)
Dynamics of Kupffer cells and stellate cells (1994) (0)
Interferon α (2017) (0)
Long-term outcome of pediatric non-cirrhotic portal fibrosis from the viewpoint of endoscopic profile (2020) (0)
Detection of cyclooxygenase and 5-lipoxygenase activity in rat hepatocytes. (1990) (0)
Title Comprehensive analysis of transcriptome and metabolome analysis in Intrahepatic Cholangiocarcinoma and Hepatocellular Carcinoma (2018) (0)
Risk factors for liver‐related and non‐liver‐related mortality following a sustained virological response after direct‐acting antiviral treatment for hepatitis C virus infection in a real‐world cohort (2022) (0)
1P162 Exogenous Ligand Binding Mechanism of Cytoglobin(5. Heme protein,Poster Session,Abstract,Meeting Program of EABS & BSJ 2006) (2006) (0)
Antifibrotic Therapy for Liver Cirrhosis (2019) (0)
Tryptophan metabolism in the liver, brain and kidney of mice with acute hepatic failure. (1988) (0)
501 18-BETA-GLYCYRRHETIC ACID, METABOLITE OF GLYCYRRHIZIN, INDUCES APOPTOSIS AND SUPPRESS THE EXPRESSION OF COLLAGEN TYPE I GENE IN HEPATIC STELLATE CELLS (2008) (0)
The impact of liver function improvement after direct-acting antiviral therapy on the outcome in hepatitis C virus patients with decompensated cirrhosis (2022) (0)
431 PRE-EMPTIVE OR PROPHYLACTIC THERAPY FOR REACTIVATION OF HEPATITIS B VIRUS IN PATIENTS WHO RECEIVED IMMUNOSUPPRESSIVE OR CYTOTOXIC THERAPY: EVALUATION OF BOTH HBsAg-POSITIVE AND HBsAg-NEGATIVE COHORTS (2013) (0)
Effect of Extract of Cultured Lentinus edodes mycelia (LEM) on Platelet Activating Factor Synthesis from Mouse Hepatic Sinusoidal Endothelial Cells (1992) (0)
The hepatic sinusoid 'classic and contemporary’: a report on the 17th international symposium on cells of the hepatic sinusoid (ISCHS) (2014) (0)
ISOLATION OF A NOVEL PROTEIN, STAP, FROM ACTIVATED STELLATE CELL BY PROTEOMICS (2001) (0)
Crystal structure of human cytoglobin at 1.68 angstroms resolution (2006) (0)
F8-6 Retinoic acid induces biphasic release and activation of latent transforming growth factor-β in rat stellate cell cultures (1995) (0)
Annual lung cancer screening by chest x-ray results in higher profits for the exclusion of lung cancer. (2019) (0)
Blood levels of leukotrienes in chronic hepatitis. (1988) (0)
Suppression of intrahepatic cholangiocarcinoma cell growth by SKI via upregulation of the CDK inhibitor p21 (2022) (0)
Long-term prognosis of patients with hepatocellular carcinoma who underwent thermal ablation therapies (2011) (0)
Significant decrease of mucosal cytoglobin+ pericryptal myofibroblasts in longstanding ulcerative colitis with colorectal neoplasia, correlatively with alpha-SMA and HSP47 phenotypic expression: P-0147. (2009) (0)
Prevalence of Hepatitis B Surface Antigen Among Apparently Healthy Individuals in Ibadan Nigeria (2018) (0)
Artificial pleural effusion and/or ascites for percutaneous radiofrequency ablation of hepatocellular carcinoma (2011) (0)
Author Correction: Development of a novel anti-hepatitis B virus agent via Sp1 (2020) (0)
Impact of alcohol abstinence on survival after hepatic resection for hepatocellular carcinoma in patients with alcohol-related liver disease (2021) (0)
Abstract 16720: Cytoglobin Regulates Cardiovascular Function and Vessel Tone by Controlling the Rate of Vascular Nitric Oxide Metabolism (2014) (0)
T lymphocyte subsets in the peripheral blood in patients with primary biliary cirrhosis. (1989) (0)
Fascin, an Actin Bundlling Protein, Can Be a Novel Marker of Human Hepatic Stellate Cells and May Regulate Functions of Hscs Through FAK-PI3K-AKT Pathway (2011) (0)
Successful direct-acting antiviral treatment of three patients with genotype 2/1 recombinant hepatitis C virus (2018) (0)
Differences between microwave coagulation and radiofrequency ablation for patients with hepatocellular carcinoma who received laparoscopic thermal ablation therapies (2010) (0)
Real-time PCR assays for hepatitis C virus RNA (genotype 1) is useful for evaluating virological response to the treatment with peginterferon-alpha2b and ribavirin. (2013) (0)
Antifibrotic agents emerging from traditional herbal medicine (2010) (0)
A case of hepatocellular carcinoma with "pseudoprogression" followed by complete response to atezolizumab plus bevacizumab. (2023) (0)
Non-heat-stressed Method to Isolate Hepatic Stellate Cells From Highly Steatotic Tumor-bearing Liver Using CD49a (2022) (0)
Network of immunological and inflammatory reaction in chronic liver disease. (1989) (0)
Leukotriene B4 in bile and culture supernatant of kupffer cells in rat (1988) (0)
Hepatocelluar Carcinoma Risk in Advanced Fibrosis After Sustained Virologic Response: When Can We Safely Stop Hepatocellular Carcinoma Surveillance? (2022) (0)
EXPRESSION OF GALECTIN-1 AND GALECTIN-3 IN HEPATIC STELLATE CELL AND FIBROTIC LIVER (2001) (0)
Development of a novel anti-hepatitis B virus agent via Sp1 (2020) (0)
Molecular and Cellular Aspects of Liver Fibrosis (2005) (0)
P652 CLINICAL CHARACTERISTICS OF HEPATITIS B VIRUS REACTIVATION IN A PROSPECTIVE LONG-TERM STUDY FOR PATIENTS WITH HEMATOLOGIC MALIGNANCY (2014) (0)
Efficacy of Polaprezinc in Patients with Hepatitis C Virus−related Liver Cirrhosis (2008) (0)
TACE for treatment-naive HCC has different treatment effects depending on central or peripheral tumor-location (2023) (0)
1168 RESPONSE GUIDED THERAPY BY PEGINTERFERON A2B PLUS RIBAVIRIN IN PATIENTS WITH HCV GENOTYPE 2 (2012) (0)
Alternative methods of radiofrequencty ablation for hepatocellular carcinoma located close to the hepatic dome (2008) (0)
Validation of a Novel Cutoff Point for the Fibrosis-4 Index Modified by Age in Patients with Fatty Liver Diseases (2021) (0)
[Drug induced liver injury]. (1995) (0)
Molecular Analysis of Stellate Cells Activation by Proteomics (2001) (0)
Analysis of Proteins and Genes Dominantly Expressed in Stellate Cells of Activated Phenotype: the Molecular Approach to Liver Fibrosis (2001) (0)
Subject Index Vol. 51, Suppl. 1, 2008 (2008) (0)
[Study on productive activity of leukotrienes in peripheral neutrophils in patients with liver disease]. (1988) (0)
98 Unique Expression of Cytoglobin/Stellate Cell Activation-Associated Protein As An Oxygen Supplier Before Angiogenesis During Gastric Ulcer Healing in Rats (2008) (0)
PROTEOMICS – Clinical Applications Table of Contents (2013) (0)
Adjuvant epoetin‐β with peginterferon‐α and ribavirin in Japanese ribavirin‐intolerant relapsed patients with chronic hepatitis C genotype 2 (2014) (0)
Abstracts of selected papers presented at the 30th Annual Meeting of the Japanese Society of Gastroenterology October 20–22, 1988 — Kagoshima, Japan (1991) (0)
Annual lung cancer screening by chest X ray to avoid further examinations. (2020) (0)
Short-term hepatocyte function and portal hypertension outcomes of sofosbuvir/velpatasvir for decompensated hepatitis C-related cirrhosis (2023) (0)
Per‐rectal portal scintigraphy as an alternative measure of hepatic venous pressure gradient in chronic liver disease: A preliminary report (2021) (0)
Inside Lab Invest (2012) (0)
Infection route of hepatitis C patients treated with direct-acting antivirals -To evaluate the risk of reinfection- (2017) (0)
Selective overexpression of cytoglobin in stellate cells attenuates thioacetamide-induced liver fibrosis in mice (2018) (0)
Author Correction: Development of a novel anti-hepatitis B virus agent via Sp1 (2020) (0)
Outcomes for Cirrhotic Patients with Hepatitis C Virus 1b Treated with Asunaprevir and Daclatasvir Combination. (2017) (0)
[Natural history of hepatitis B virus infection]. (2011) (0)
Crystal Structure of Human Cytoglobin (Ferric Form) (2004) (0)
Last crusade against HCV: Direct‐acting antiviral treatment for marginalized populations (2019) (0)
A case of ectopic hepatocellular carcinoma originating from the retroperitoneum (2020) (0)
Molecular Mechanism and Emerging Therapy of Liver Fibrosis (2018) (0)
Laparoscopic observation of 2 cases of nodular regenerative hyperplasia of the liver. (2007) (0)
The regulatory mechanism by extracellular nucleotides in hepatic microcirculation (1995) (0)
Galectin-1 as a novel mitogen for hepatic stellate cells (2002) (0)
131 A STUDY ON A RABBIT MODEL OF STEATOHEPATITIS WITH ADVANCED FIBROSIS (2009) (0)
Polymorphisms in MICA, but not in DEPDC5, HCP5 or PNPLA3, are associated with chronic hepatitis C-related hepatocellular carcinoma (2017) (0)
Monitoring patients with a resolved hepatitis B virus infection for HBV reactivation (2018) (0)
Effect of alendronate on bone loss in patients with cirrhosis of the liver (2006) (0)
Medium-term outcomes of hepatitis C virus-infected patients with a sustained viral response according to albumin-bilirubin grade (2020) (0)
Stress can attenuate hepatic lipid accumulation via elevation of hepatic β-muricholic acid levels in mice with nonalcoholic steatohepatitis. (2021) (0)
Induction of activated T-cell apoptosis by activated hepatic stellate cells in the rat liver (2002) (0)
Sa128 CYTOGLOBIN IMPAIRS PANCREATIC CANCER GROWTH IN VITRO AND IN VIVO (2021) (0)
REDOX-REGULATED CELL GROWTH MEDIATED BY CATHEPSIN B-DEPENDENT EXTRACELLULAR PROTEOLYSIS OF PLATELET-DERIVED GROWTH FACTOR RECEPTOR. (2001) (0)
Correction: Stagnation of histopathological improvement is a predictor of hepatocellular carcinoma development after hepatitis C virus eradication (2018) (0)
Is it possible to stop nucleus(t)die analogue safely in patients with preemptive or preventive therapy for HBV reactivation? (2020) (0)
Platelet activating factor(PAF) and interleukin-1 synthesis by hepatic sinusoidal endothelial cells from mice with carbon tetracholoride liver cell injury. (1990) (0)
Severity of Liver Fibrosis Is Associated with the Japanese Diet Pattern and Skeletal Muscle Mass in Patients with Nonalcoholic Fatty Liver Disease (2023) (0)
[Indication of monotherapy with pegylated interferon or interferon for patient with HCV in Japan]. (2011) (0)
A case of adult-onset Still's disease with macrophage activation syndrome and acute liver failure (2012) (0)
971 MICRORNA-29B SUPPRESSES TYPE I COLLAGEN AND SP1 EXPRESSION IN INTERFERON-TREATED STELLATE CELLS (2010) (0)
Molecular and cellular analysis of stellate cell activation -associated protein (STAP) (2002) (0)
Clinical significance of circulating soluble immune checkpoint proteins in sorafenib-treated patients with advanced hepatocellular carcinoma (2020) (0)
TNP-470 INHIBITS HEPATIC FIBROSIS OF RATS INDUCED BY CARBON TETRACHLORIDE (CCL_4) AND DIMETHELNITROSAMINE (DMN) (2001) (0)
589 The incidence of hepatocellular carcinoma in patients with chronic hepatitis C who achieved sustained virological response to interferon therapy (2006) (0)
2P003 Ligand binding mechanism of human Cytoglobin based on X-ray crystal structure (2004) (0)
CELL CULTURE IN THREE-DIMENSIONAL LATTICES OF HYDRATED COLLAGEN FIBRILS − ITS PROGRESS AND PERSPECTIVES (2015) (0)
Laparoscopic thermal ablation therapy for hepatocellular carcinoma with forward-viewing laparoscopic ultrasonography (End-Fire array) (2008) (0)
133 CYTOGLOBIN-DEFICIENCY PROMOTES THE DEVELOPMENT OF LIVER CANCER IN MOUSE MODELS VIA THE ACTIVATION OF LOCAL FIBROSIS, INFLAMMATION AND OXIDATIVE STRESS (2013) (0)
Effects of Sho-saiko-to on the Level of Cytosol Esradiol Receptors (1991) (0)
Multicenter, retrospective, cohort study shows platelet counts predict hepatocellular carcinoma development in patients with nonalcoholic fatty liver disease (2023) (0)
Indication and results of thermal ablation for hepatocellular carcinoma (2007) (0)
A mask-based infection control method for screening endoscopy may prevent SARS-CoV-2 transmission and relieve staff anxiety (2021) (0)
Development of ultrasound-assisted fluorescence imaging of indocyanine green (2016) (0)
Sulfur-containing amino acids attenuate the stellate cell proliferation and the progress of liver fibrosis in rats (2003) (0)
Abstract 2894: Intracellular gap formation of the liver sinusoidal endothelial cells facilitates the liver metastasis ability of cancer cells (2021) (0)
Stimulation of proliferation of hepatic stellate cells by galectin-1 and galectin-3 through different intracellular signaling pathways (2003) (0)
330 Targeted expression of transgenes in hepatic stellate cells using an adenoviral CRE-IoxP system to antagonize hepatic fibrosis (2006) (0)

This paper list is powered by the following services:

What Schools Are Affiliated With Norifumi Kawada?

Norifumi Kawada is affiliated with the following schools:

Osaka Metropolitan University